adalimumab（Humira）為一種抗腫瘤壞死因子（anti-TNF）之單株抗體，最不建議用於治療下列何種疾病？
Crohn’s disease
ankylosing spondylitis
rheumatoid arthritis
systemic lupus eryhematosus
